Reconsidering blood refusal: Implications of updated Jehovah’s Witness acceptance of autologous transfusion
Clinical Hematology International · 29.10.2026 · 8 (4)
DOI: 10.46989/001c.172919 ↗Kurz gefasst
Leserbrief in der Zeitschrift Clinical Hematology International, online erschienen am 29.10.2026. Verfasst von Raeshun T Glover und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, University Hospitals Cleveland Medical Center, Case Western Reserve University, Cleveland, OH 44106, USA. Die Arbeit nennt 11 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Refusal of blood transfusion has historically been associated with members of the Jehovah’s Witness (JW) faith. As such, a range of transfusion-sparing strategies have been developed for these individuals and others who refuse standard blood transfusion. Techniques that maintain blood in continuous circuit with the patient are often acceptable and have been used in operative settings, including cell salvage and acute normovolemic hemodilution. By contrast, blood that has been collected and stored for later use has traditionally been considered unacceptable, which has limited the use of both allogeneic and autologous blood products. A March 2026 update by the governing body of Jehovah’s Witnesses, The Watch Tower Bible and Tract Society of Pennsylvania, moves decisions about the storage and reinfusion of a patient’s own blood into the realm of individual conscience, which may expand the use of autologous transfusion. Given this change, requests for autologous transfusion from JW patients may increase. In this letter, we offer practical guidance on balancing respect for patient autonomy and religious belief with the medical and logistical challenges of autologous blood transfusion.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pathology, University Hospitals Cleveland Medical Center, Case Western Reserve University, Cleveland, OH 44106, USA.
- Department of Pathology University Hospitals Cleveland Medical Center.
- Department of Pathology, University of Texas Southwestern Medical Center, Dallas, USA.
- Children's Health, Dallas, Texas, USA.
- Department of Pathology, Microbiology and Immunology, Vanderbilt University, Nashville, Tennessee, USA.
- Division of Hematology-Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.
Zitieren
APA
Glover, R. T., Adkins, B. D., Booth, G. S., Savani, B. N., & Jacobs, J. W. (2026). Reconsidering blood refusal: Implications of updated Jehovah’s Witness acceptance of autologous transfusion. Clinical Hematology International, 8(4). https://doi.org/10.46989/001c.172919
Vancouver
Glover RT, Adkins BD, Booth GS, Savani BN, Jacobs JW. Reconsidering blood refusal: Implications of updated Jehovah’s Witness acceptance of autologous transfusion. Clinical Hematology International. 2026;8(4). doi:10.46989/001c.172919
BibTeX
@article{Glover2026,
author = {Glover, Raeshun T and Adkins, Brian D and Booth, Garrett S and Savani, Bipin N and Jacobs, Jeremy W},
title = {Reconsidering blood refusal: Implications of updated Jehovah’s Witness acceptance of autologous transfusion},
journal = {Clinical Hematology International},
year = {2026},
volume = {8},
number = {4},
doi = {10.46989/001c.172919}
}
EUVIMED